bimekizumab
ucb pharmaceuticals
['axspa', 'bimekizumab']
bimekizumab (bkz) in axspa to wk52 sustained efficacy suppression of inflammation improvements in function and quality of life no new safety signals were observed consistent with the safety profilewk24 data
baraliakos #l14 #acr22 
MD PhD Consultant Rheumatologist &Physician,Assoc Medical Director,Digital Leader,NASS Trustee &Best Rheum Care,Visiting Fellow Henley Business School,ExecCoach